Axogen, Inc. Readies for Financial Results Announcement
Axogen, Inc. (NASDAQ: AXGN), a renowned leader in developing surgical solutions for injuries to peripheral nerves, is gearing up to report its financial results for the third quarter of 2024. This announcement is scheduled to take place on a notable day, November 7, 2024, before the stock market opens. The management team at Axogen will follow up the release with a conference call targeted at the investment community, beginning at 8 a.m. ET.
How to Participate in the Conference Call
Investors looking to engage in the conference call can dial in using a toll-free number available to U.S. callers. The number is (877) 407-0993, with a direct dial option at (201) 689-8795 for those outside the U.S. Additionally, there will be a live audio webcast accessible via the Investors page on Axogen's website. Simply navigate to www.axogeninc.com and click on the link for the webcast to listen in.
Replay Availability After the Call
For those who may not be able to attend the live call, Axogen will provide a replay available shortly after the event. It will be located on the Investors section of their website, ensuring that all stakeholders have access to the valuable information discussed during the call.
About Axogen and Its Mission
With a strong commitment to enhancing patient recovery, Axogen (AXGN) focuses exclusively on the science, development, and marketing of technologies that assist in the regeneration and repair of peripheral nerves. The company is deeply passionate about improving the quality of life for patients who experience nerve damage. Its innovative solutions aim to restore necessary nerve functions affected by injuries or surgical interventions. Peripheral nerves serve as vital communication pathways for both motor functions and sensory signals throughout the body.
The Impact of Peripheral Nerve Injuries
Every day, many individuals face traumatic injuries or surgical procedures that disrupt normal peripheral nerve operations. The aftermath of peripheral nerve damage can lead to significant challenges, including the potential loss of muscle capability, loss of sensory perception, and the onset of chronic pain. Axogen’s product offerings include a diverse range of solutions designed for various surgical settings, addressing both urgent and elective procedures.
Innovative Solutions in Peripheral Nerve Repair
Axogen's platform features a wide array of products catering to the complex needs of peripheral nerve repair. Among these solutions is the Avance Nerve Graft®, a unique allograft that provides a clinically viable option for bridging severed nerves without requiring an additional surgical site. Another key product is the Axoguard Nerve Connector®, which utilizes a porcine submucosa extracellular matrix to facilitate a tension-free nerve repair.
Comprehensive Product Portfolio
The Axogen product lineup also includes Axoguard Nerve Protector®, designed to wrap and shield damaged nerves, and Axoguard HA+ Nerve Protector™, which incorporates advanced materials for enhanced nerve gliding. Additionally, their Avive+ Soft Tissue Matrix™ serves businesses in preserving and separating tissues during crucial surgical repair phases. The Axogen Nerve Cap® also plays a key role in protecting nerve endings from further injury.
Global Reach of Axogen's Products
The innovative range of Axogen products is not limited to a particular region; it is available in the United States, Canada, the United Kingdom, South Korea, and numerous other international markets. This expansive availability allows Axogen to cater to diverse patient requirements and solidifies its reputation as a leader in peripheral nerve repair technologies.
Contact Information for Investors
For further inquiries or information regarding Axogen, Inc., interested parties can reach out to their Investor Relations team via email at InvestorRelations@axogeninc.com. This proactive approach ensures that all investor questions are addressed timely and thoroughly.
Frequently Asked Questions
What is the date of Axogen's financial report for Q3 2024?
Axogen will report its financial results for Q3 2024 on November 7, 2024.
How can investors participate in the conference call?
Investors can join the conference call by calling (877) 407-0993 or (201) 689-8795, or by accessing the webcast on Axogen's website.
Where can the conference call replay be found?
The replay of the conference call will be available on the Investors section of Axogen's website after the event.
What types of products does Axogen offer?
Axogen offers innovative products for peripheral nerve repair, including nerve grafts and protective solutions used in various surgical applications.
In which markets are Axogen's products available?
Axogen's products are available in the U.S., Canada, the U.K., South Korea, and several other European and international markets.
